Common core structure of amyloid fibrils by synchrotron X-ray diffraction.

  title={Common core structure of amyloid fibrils by synchrotron X-ray diffraction.},
  author={Margaret Sunde and Louise C. Serpell and Mark Bartlam and Paul E. Fraser and Mark B. Pepys and Colin C. F. Blake},
  journal={Journal of molecular biology},
  volume={273 3},
Tissue deposition of normally soluble proteins as insoluble amyloid fibrils is associated with serious diseases including the systemic amyloidoses, maturity onset diabetes, Alzheimer's disease and transmissible spongiform encephalopathy. Although the precursor proteins in different diseases do not share sequence homology or related native structure, the morphology and properties of all amyloid fibrils are remarkably similar. Using intense synchrotron sources we observed that six different ex… 

Figures from this paper

The common architecture of cross-beta amyloid.

Review: structure of amyloid fibril in diseases

Structural models have been made using information from a wide variety of techniques, including electron microscopy, X-ray diffraction, solid state NMR, and Congo red and CD spectroscopy, showing structural similarity that defines amyloid fibres exists principally at the level of β-sheet folding of the polypeptides within the protofilament.

The protofilament substructure of amyloid fibrils.

Cross-correlation techniques are used to average electron microscopy images of multiple cross-sections in order to reconstruct the sub-structure of ex vivo amyloid fibrils composed of amyloids A protein, monoclonal immunoglobulin lambda light chain, Leu60Arg variant apolipoprotein AI, and Asp67His variant lysozyme.

Structure and morphology of the Alzheimer's amyloid fibril

In combination with other techniques, including X‐ray fiber diffraction and solid state NMR, electron microscopy has revealed that the internal structure of the amyloid fibril is a ladder of β‐sheet structure arranged in a cross‐β conformation.

Structural polymorphism of Alzheimer Aβ and other amyloid fibrils

Deposits of amyloid fibrils characterize a diverse group of human diseases that includes Alzheimer’s disease, Creutzfeldt-Jakob disease and type II diabetes, and can occur in a range of structurally different morphologies.

Direct visualisation of the beta-sheet structure of synthetic Alzheimer's amyloid.

The core structure of an Alzheimer's amyloid fibril is revealed by direct visualisation using cryo-electron microscopy to help understand the abnormal assembly and deposition of these fibrils and could lead to the rational design of therapeutic agents for their prevention or disaggregation.

Polymorphism in an amyloid-like fibril-forming model peptide.

Solid-state NMR spectroscopy, and more specifically rotational echo double-resonance (REDOR) experiments, are a powerful tool to unambiguously determine the register of constituent b strands within an amyloid fibril.

Structural diversity of ex vivo amyloid fibrils studied by cryo-electron microscopy.

It is concluded that ex vivo amyloid fibrils, although variable, assemble as characteristic structures according to the identity of the precursor protein.

The formation of amyloid fibrils by relaxin

Amyloid is characterised by a typical ‘cross-13’ X-ray diffraction pattern indicative of a stacked 13-sheet structure in which the strands are arranged perpendicular to the fibril axis; by a long, unbranched appearance under electron microscopy; and by staining with the dye Congo Red, which exhibits a green birefringence when viewed under polarised light.

X-ray fibre diffraction studies of amyloid fibrils.

The methods by which amyloid-like fibrils may be prepared to form a sample suitable for structural analysis are discussed and how data may be collected and then analysed to arrive at a potential model structure are described.



X-ray scattering and diffraction by wet gels of AA amyloid fibrils.

It is shown that a stack of anti-parallel sheets is not consistent with the details of the X-ray pattern, which contains diffracted intensities that can be indexed on a 33A X 33A lattice.

Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.

These findings on these homologous synthetic assemblies help to define the specific sequence that is required to form Alzheimer-type amyloid fibrils, thus providing an in vitro model of age-related cerebral amyloidsogenesis.

X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation.

The cross-beta conformation of PHF and amyloid fibers that the authors have found from x-ray diffraction is in contrast to the predominant alpha-helical coiled-coil conformed of the neurofilaments with which they share epitopes and from which they have been postulated to derive.

Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis

Biophysical studies suggest that partly folded intermediates are involved in fibrillogenesis, and this may be relevant to amyloidosis generally.

A molecular model of the amyloid fibril.

This newly-described helix reconciles the classical cross-beta structure of amyloid with the twisted beta-sheet that is known to be the most stable form of the structure.

Structural studies on FAP fibrils: removal of contaminants is essential for the interpretation of X-ray data

Amyloid fibrils were isolated from heterozygous Met 30 familial amyloidotic polyneuropathy patients and X-ray diffraction experiments indicate the presence of a lipid structure in all the samples that had not been previously delipidated.

Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs.

Amyloid material from the vitreous humours of patients homozygous for this mutation is used and the structure of the fibrils is analysed by thin section electron microscopy and image reconstruction.